CELL FREE DNA-BASED PREDICTION OF PROGNOSIS FOR PATIENTS ON VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION.

Summary: Doctors have identified a powerful new way to monitor critically ill heart patients on life support (ECMO). By measuring "cell-free DNA"—fragments of genetic material released into the bloodstream when cells die—medical teams can better predict patient outcomes. A recent study found that high levels of this DNA debris within the first 48 hours of treatment are strong warning signs. Patients with elevated cell-free DNA were more likely to face life-threatening complications, particularly severe circulation loss in the legs (limb ischemia), and had a higher risk of death. This simple blood test could help doctors intervene earlier to save lives and limbs.